AXTA AXTA
Company Profile ↓Company Overview
AXTA (AXTA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 16.1%, reflecting efficient use of shareholder capital.
Net profit has compounded at 26.9% per year over the last five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $5.12B (-3.0% YoY); net profit $378.00M.
- Trailing 12 Months Year-on-year growth — revenue -3.0%, earnings -3.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.4%, profit CAGR 26.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.40% |
| 1 Year: | -3.01% |
Compounded Profit Growth
| 5 Years: | 26.94% |
| 1 Year: | -3.32% |
Stock Price Performance
| 1 Year: | +35.58% |
| 6 Months: | +17.97% |
| 3 Months: | +40.17% |
| 1 Month: | +11.15% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)72.11 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 26.9% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 1.17B | 1.21B | 1.15B | - | 1.12B | 1.16B | 1.11B | - | 983.50M | 652.70M | 1.03B | - | 1.06B | 1.13B | 1.09B | 1.17B | 1.23B | 1.24B | 1.28B | 1.29B | 1.31B | 1.29B | 1.35B | 1.32B | 1.26B | 1.30B | 1.29B | 1.25B |
| Operating Income | 101.80M | 143.00M | 123.90M | - | 103.30M | 149.50M | 117.40M | - | 110.40M | 47.50M | 103.90M | 101.90M | 120.00M | 146.50M | 47.80M | 127.80M | 98.60M | 157.90M | 123.00M | 108.70M | 65.10M | -64.50M | 141.70M | 163.20M | 52.60M | 190.40M | 124.70M | 86.30M | 103.60M | 123.50M | 125.00M | 138.00M | 163.00M | 121.00M | 205.00M | 193.00M | 176.00M | 193.00M | 204.00M | 146.00M |
| Net Income | 45.10M | -25.10M | 35.10M | 38.60M | 31.90M | 50.70M | -6.60M | -37.20M | 64.10M | -20.80M | 54.90M | -61.50M | 69.90M | 74.90M | -13.10M | 75.40M | 43.40M | 98.40M | 65.50M | 41.70M | 52.20M | -82.80M | 82.50M | 69.70M | 15.20M | 126.40M | 69.10M | 41.50M | 44.10M | 62.40M | 61.00M | 61.00M | 72.00M | 41.00M | 112.00M | 101.00M | 99.00M | 109.00M | 110.00M | 90.00M |
| Diluted EPS | 0.19 | -0.11 | 0.15 | 0.16 | 0.13 | 0.21 | -0.03 | -0.16 | 0.26 | -0.09 | 0.22 | -0.26 | 0.28 | 0.31 | -0.05 | 0.32 | 0.18 | 0.42 | 0.28 | 0.18 | 0.22 | -0.35 | 0.35 | 0.30 | 0.06 | 0.54 | 0.30 | 0.18 | 0.20 | 0.28 | 0.27 | 0.27 | 0.33 | 0.18 | 0.51 | 0.46 | 0.45 | 0.50 | 0.51 | 0.42 |
| R&D Expense | 12.90M | 12.80M | 13.00M | - | 12.60M | 14.10M | 14.90M | - | 15.60M | 16.40M | 16.60M | - | 19.30M | 18.00M | 17.00M | - | 18.20M | 17.90M | 17.40M | - | 16.60M | 11.20M | 13.40M | - | 15.60M | 15.80M | 15.40M | 16.40M | 16.70M | 16.50M | 19.00M | 19.00M | 18.00M | 18.00M | 18.00M | 19.00M | 17.00M | 20.00M | 18.00M | 18.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.39B | 4.11B | 4.07B | 4.38B | 4.70B | 4.48B | 3.74B | 4.42B | 4.88B | 5.18B | 5.28B | 5.12B |
| Operating Income | 369.50M | 465.60M | 405.10M | 363.70M | 442.10M | 488.20M | 305.50M | 462.40M | 423.00M | 588.00M | 706.00M | 735.00M |
| Net Income | 27.40M | 91.60M | 38.80M | 36.70M | 207.10M | 249.00M | 121.60M | 263.90M | 192.00M | 267.00M | 391.00M | 378.00M |
| Diluted EPS | 0.12 | 0.38 | 0.16 | 0.15 | 0.85 | 1.06 | 0.52 | 1.14 | 0.86 | 1.21 | 1.78 | 1.74 |
| R&D Expense | 49.50M | 51.60M | 57.70M | 65.30M | 73.10M | 70.20M | 55.20M | 62.40M | 66.00M | 74.00M | 74.00M | 71.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 5.83B | 5.87B | 6.83B | 6.68B | 6.82B | 7.16B | 7.22B | 7.06B | 7.27B | 7.25B | 7.60B |
| Total Equity | 1.21B | 1.11B | 1.07B | 1.13B | 1.28B | 1.21B | 1.35B | 1.43B | 1.49B | 1.45B | 1.73B | 1.91B | 2.35B |
| Cash & Equivalents | - | 382.10M | 485.00M | 535.40M | 769.80M | 693.60M | 1.02B | 1.36B | 840.60M | 645.00M | 700.00M | 593.00M | 657.00M |
| Long Term Debt | - | - | - | 3.30B | 3.95B | 3.89B | 3.88B | - | 3.86B | 3.67B | 3.48B | 3.40B | 3.18B |
| Total Liabilities | - | - | 4.69B | 4.62B | 5.42B | 5.37B | 5.41B | 5.68B | 5.68B | 5.56B | 5.50B | 5.29B | 5.21B |
| Current Liabilities | - | - | 875.00M | 942.10M | 1.08B | 1.04B | 1.07B | 1.18B | 1.33B | 1.38B | 1.43B | 1.35B | 1.37B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | 540.00M | 496.10M | 573.10M | 509.30M | 558.60M | 294.00M | 575.00M | 576.00M | 649.00M |
| Investing Cash Flow | - | - | - | -689.60M | -189.20M | -93.90M | -61.50M | -716.00M | -106.00M | -206.00M | -440.00M | -212.00M |
| Financing Cash Flow | - | - | - | 367.30M | -368.20M | -158.40M | -130.90M | -334.50M | -369.00M | -315.00M | -201.00M | -401.00M |
| Capital Expenditure | -188.40M | -138.10M | -136.20M | -125.00M | -143.40M | -112.50M | -82.10M | -121.60M | -151.00M | -138.00M | -140.00M | -196.00M |
| Free Cash Flow | - | - | - | 415.00M | 352.70M | 460.60M | 427.20M | 437.00M | 143.00M | 437.00M | 436.00M | 453.00M |
| Share Buybacks | - | 0 | 0 | 58.40M | 253.80M | 105.30M | 26.00M | 243.80M | 200.00M | 50.00M | 100.00M | 165.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 8.4% | 11.3% | 10.0% | 8.3% | 9.4% | 10.9% | 8.2% | 10.5% | 8.7% | 11.3% | 13.4% | 14.4% |
| Net Margin % | 0.6% | 2.2% | 1.0% | 0.8% | 4.4% | 5.6% | 3.3% | 6.0% | 3.9% | 5.2% | 7.4% | 7.4% |
| ROE % | 2.5% | 8.5% | 3.4% | 2.9% | 17.2% | 18.4% | 8.5% | 17.7% | 13.2% | 15.5% | 20.4% | 16.1% |
| ROCE % | - | 9.4% | 8.2% | 6.3% | 7.8% | 8.5% | 5.1% | 7.9% | 7.5% | 10.1% | 12.0% | 11.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AXTA
Axalta (NYSE: AXTA) investors approve AkzoNobel merger of equals - Stock Titan
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQZTFybEFaVzJDUjl1MTBoaUh2YVhFVW9mdWhPS1dHbjNJcTV5VXk1RVRpSEdUOVF2ODB0Wk5QaWwwcVkxSzlleVVtZmw1blJMQWViSkZaNjZGTVYyRXp4MEp0cXZDaGZFMmxaM05nQVlSSzNJd2lmM0s0eV9DdU4yVVlhRXZCZ0JrSlloTU…
Axalta Shareholders Approve All-Stock Merger of Equals with AkzoNobel - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPRzZsNENxQ2FZcnVvTEZTV0NnclpSRHRfQkl5NFJTdll0N3dnR2RwR2xNYjR0d1c5YXFjcDhjbkZkN1doOXYxeVVPTzNXQmFxeF8waEJINEdZbGF3UElTekpMRDJBWFI4V3V3bzZ0QUxZcjZWTTdJTFkxUkY2STRheG5XaGx2YzNkNmQ3am…
Is Axalta Coating Systems (AXTA) Stock Outpacing Its Basic Materials Peers This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNOXN5T2VabUV4YXBiX3lyMEpnSFZDcHpWSlQwNWlodWJ4OGRNWldzbVpDMTBYdVRMN3JqNU15NFQ4eTRaVUY0Z3g1aU5JWmdFSzBlTFhYVlJscU9MUDBJSzU1VG4tV3J2d3hiSlFKTXRzQlUyczd5NXRWalFpclh0WHpMS1VoNWtqYWJTQS…
Axalta Coating Systems stock hits 52-week high at 37.87 USD - Investing.com
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQZDdQUWJXQ2VYNV9jZ0Q0WjFpMEEtVVRidmdEaFJUZGo4X3YxczBPaUFmWFJNUGxXMEZoY3dXNG9lVEZuZDBGa0lhMUFCOFZ4SHZraTNpZXFiSktJdzN6VlhKSXd3NFk1ZjZaSU42SnJKUU1uX1kwcXNFcXhaNWJuMUtENGwyVDZEeVpEem…
Axalta Shareholders Approve Proposed Merger of Equals with AkzoNobel - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQVVFPMmdKS0kxRFRjd29NdjZXQ2VpbGhFMnI1XzNzYW5HbE05RkllSFpkckZMOWFwTHE0TEt6dVVZQlEyTTduT21JTVNDd0NUYjJJaDlhVExvbDkwbWFOZ1RvUnZRZ3V3Z0F1UDR1VmhUeUFZQmpuQ2xWVHZwcHQ1cURCMHI5VEFTeWQ5Wn…
Is Axalta (AXTA) Sacrificing Margin Ambitions as Sales Grow but Earnings Soften? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQU05yUVVKQWhVWHhwNzZvakNMSk9GTWNMRlJ4WjNzQ0RqXzQwUDJld3U3UDR2ZmlXak1udUE0NjFpMkNhTHhFQk5WYVJzeHpGT0pZVF9UU013MjJDZV9oZ2sxQlM3bUd5dE5IaXQtZDBUdFRBejdZMzdVM3V6a2szcjE0SDh6VkN1Uzg2aW…
AXTA — Frequently Asked Questions
What is the current share price of AXTA?
As of 2026-08-05 17:25 PDT, AXTA trades at $38.07 on NASDAQ/NYSE. Its 52-week range is $25.44 to $38.07.
What is the P/E ratio of AXTA?
AXTA trades at a trailing price-to-earnings (P/E) ratio of 21.88.
What is the return on equity (ROE) of AXTA?
AXTA has a return on equity (ROE) of 16.11%. Its return on capital employed (ROCE) is 11.80%.
Is AXTA a good stock to buy?
This page provides a data-driven analysis of AXTA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.